PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 17, 2026Journal of Drug Delivery and TherapeuticsOpen Access

Development and Validation of Stability Indicating RP-HPLC Method for the Estimation of Lasmiditan in tablet dosage form

View Full Paper
Ask AI
Bookmark
Share

Authors

RDRahul Ramhari DaradeSWSagar B. Wankhede

Discussion

Loading...

Member takes

Overview

Analytical method demonstrates high accuracy and stability for lasmiditan measurement in tablets, indicating reliability for quality control.

Key Points

  • The aim is to develop and validate a reliable RP-HPLC method for estimating lasmiditan in tablet dosage forms.
  • Selection and optimization of mobile phase composition for HPLC.
  • Utilization of standard analytical guidelines from ICH and USP.
  • Validation of method based on criteria such as accuracy, precision, and robustness.
  • The method demonstrates high accuracy and reproducibility in measuring lasmiditan.
  • Validation confirms specificity and sensitivity for quality control applications.

Cite This Study

Darade et al. (2026) studied this question.

synapsesocial.com/papers/696b2655d2a12237a9349aa4https://doi.org/10.22270/jddt.v16i1.7516
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Stability-Indicating RP-HPLC Method Development, Qbd Optimization and Validation for assessing Related Impurities in Labetalol Hydrochloride bulk and injectable form2024
  2. 2Analytical quality by design (AQbD)-assisted bioanalytical method for the estimation of Lasmiditan in human plasma by reverse phase–high performance liquid chromatography (RP-HPLC)2026 · 1 citations
  3. 3Stability‐indicating RP‐HPLC method development and validation for the quantification of amlodipine besylate and valsartan tablets in solid oral dosage form2024 · 7 citations
  4. 4"RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF LINEZOLID AND DAPTOMYCIN AND THEIR IMPURITIES."2026
  5. 5STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION OF LACOSAMIDE AND ITS RELATED SUBSTANCES IN PHARMACEUTICAL FORMULATION BY RP-HPLC2026